Книга Пятый элемент здоровья. Как использовать менструальный цикл для поддержания жизненно важных функций организма - Лиза Хендриксон-Джек

contraceptives.” Gynecological Endocrinology 16, no. 4 (2002): 311–313.

4. Jacobs, H.S., U.A. Knuth, M.G. Hull, and S. Franks. “‘Post-pill’ amenorrhoea – cause or coincidence?” The BMJ 2, no. 6092 (1977): 940–942; Steele, S.J., Bridgett Mason, and Ann Brett. “Amenorrhoea after discontinuing combined oestrogen-progestogen oral contraceptives.” The BMJ 4, no. 5888 (1973): 343; Rojas-Walsson, R., and R. Cardoso. “Diagnosis and management of post-pill amenorrhea.” The Journal of Family Practice 13, no. 2 (1981): 165–169.

5. Larsson-Cohn, Ulf. “The length of the first three menstrual cycles after combined oral contraceptive treatment.” Acta Obstetricia et Gynecologica Scandinavica 48, no. 3 (1969): 416–422.

6. Там же.

7. Kushnir, Vitaly A., David H. Barad, and Norbert Gleicher. “Ovarian reserve screening before contraception?” Reproductive Biomedicine Online 29, no. 5 (2014): 527–529.

8. Steele, S.J., Bridgett Mason, and Ann Brett. “Amenorrhoea after discontinuing combined oestrogen-progestogen oral contraceptives.” The BMJ 4, no. 5888 (1973): 343.

9. Там же.

10. Deb, S., B.K. Campbell, C. Pincott-Allen, J.S. Clewes, G. Cumberpatch, and N.J. Raine-Fenning. “Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.” Ultrasound in Obstetrics & Gynecology 39, no. 5 (2012): 574–580; Bentzen, J G., Julie Lyng Forman, Anja Pinborg, Ø. Lidegaard, E.C. Larsen, L. Friis-Hansen, Trine Holm Johannsen, and A. Nyboe Andersen. “Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.” Reproductive Biomedicine Online 25, no. 6 (2012): 612–619; D’Arpe, Stella, Mara Di Feliciantonio, Miriam Candelieri, Silvia Franceschetti, Maria Grazia Piccioni, and Carlo Bastianelli. “Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review.” Reproductive Biomedicine Online 33, no. 4 (2016): 436–448; Birch Petersen, K., H.W. Hvidman, J.L. Forman, A. Pinborg, E.C. Larsen, K.T. Macklon, R. Sylvest, and A. Nyboe Andersen. “Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.” Human Reproduction 30, no. 10 (2015): 2364–2375; Christensen, Jeanette T., Jesper Boldsen, and Jes G. Westergaard. “Ovarian volume in gynecologically healthy women using no contraception, or using IUD or oral contraception.” Acta Obstetricia et Gynecologica Scandinavica 76, no. 8 (1997): 784–789.

11. Birch Petersen, K., H.W. Hvidman, J.L. Forman, A. Pinborg, E.C. Larsen, K.T. Macklon, R. Sylvest, and A. Nyboe Andersen. “Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.” Human Reproduction 30, no. 10 (2015): 2364–2375.

12. Deb, S., B.K. Campbell, C. Pincott-Allen, J.S. Clewes, G. Cumberpatch, and N.J. Raine-Fenning. “Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.” Ultrasound in Obstetrics & Gynecology 39, no. 5 (2012): 574–580.

13. Wu, Cheng-Hsuan, Yu-Ching Chen, Hsin-Hung Wu, Jyuer-Ger Yang, Yu-Jun Chang, and Horng-Der Tsai. “Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.” Journal of Assisted Reproduction and Genetics 26, no. 7 (2009): 383–389.

14. Bentzen, J.G., Julie Lyng Forman, Anja Pinborg, Ø. Lidegaard, E.C. Larsen, L. Friis-Hansen, Trine Holm Johannsen, and A. Nyboe Andersen. “Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.” Reproductive Biomedicine Online 25, no. 6 (2012): 612–619; Deb, S., B.K. Campbell, C. Pincott-Allen, J.S. Clewes, G. Cumberpatch, and N.J. Raine-Fenning. “Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three– dimensional ultrasound.” Ultrasound in Obstetrics & Gynecology 39, no. 5 (2012): 574–580; Birch Petersen, K., H.W. Hvidman, J.L. Forman, A. Pinborg, E.C. Larsen, K.T. Macklon, R. Sylvest, and A. Nyboe Andersen. “Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.” Human Reproduction 30, no. 10 (2015): 2364–2375.

15. Там же.

16. Letourneau, Joseph M., Hakan Cakmak, Molly Quinn, Nikita Sinha, Marcelle I. Cedars, and Mitchell P. Rosen. “Long-term hormonal contraceptive use is associated with a reversible suppression of antral follicle count and a break from hormonal contraception may improve oocyte yield.” Journal of Assisted Reproduction and Genetics 34, no. 9 (2017): 1137–1144.

17. Barnhart, Kurt T., and Courtney A. Schreiber. “Return to fertility following discontinuation of oral contraceptives.” Fertility and Sterility 91, no. 3 (2009): 659–663; Mikkelsen, Ellen M., Anders H. Riis, Lauren A. Wise, Elizabeth E. Hatch, Kenneth J. Rothman, and Henrik Toft Sørensen. “Pre-gravid oral contraceptive use and time to pregnancy: a Danish prospective cohort study.” Human Reproduction 28, no. 5 (2013): 1398–1405; Bracken, Michael B., Karen G. Hellenbrand, and Theodore R. Holford. “Conception delay after oral contraceptive use: the effect of estrogen dose.” Fertility and Sterility 53, no. 1 (1990): 21–27; Linn, S., S.C. Schoenbaum, R.R. Monson, B. Rosner, and K.J. Ryan. “Delay in conception for former ‘pill’ users.” JAMA 247, no. 5 (1982): 629; Doll, Helen, Martin Vessey, and Rosemary Painter. “Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception.” BJOG: An International Journal of Obstetrics and Gynaecology 108, no. 3 (2001): 304–314.

18. Hassan, M A.M., and S.R. Killick. “Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity?” Human Reproduction 19, no. 2 (2004): 344–351.

19. Там же.

20. Bracken, Michael B., Karen G. Hellenbrand, and Theodore R. Holford. “Conception delay after oral contraceptive use: the effect of estrogen dose.” Fertility and Sterility 53, no. 1 (1990): 25.

21. Linn, Shai, Stephen C. Schoenbaum, Richard R. Monson, Bernard Rosner, and Kenneth J. Ryan. “Delay in conception for former ‘pill’ users.” JAMA 247, no. 5 (1982): 629–632.

22. Berg, J.M., J.L. Tymoczko, and L. Stryer. (2002). Biochemistry, 5th edition. Section 26.4, Important Derivatives of Cholesterol Include Bile Salts and Steroid Hormones. New York, NY: W.H. Freeman.

23. Suwa, Hiroto, Hiroshi Kishi, Fumiharu Imai, Kohshiro Nakao, Takashi Hirakawa, and Takashi Minegishi. “Retinoic acid enhances progesterone production via the cAMP/PKA signaling pathway in immature rat granulosa cells.” Biochemistry and Biophysics Reports 8 (2016): 62–67; Talavera, F., and B. P. Chew. “Comparative role of retinol, retinoic acid and β-carotene on progesterone secretion by pig corpus luteum in vitro.” Journal of Reproduction and Fertility 82, no. 2 (1988): 611–615; Pethes, G., E. Horvath, M. Kulcsar, Gy Huszenicza, Gy Somorjai, B. Varga, and J. Haraszti. “In vitro progesterone production of corpus